2025-08-26 – Press Releases – www.prnewswire.com
Abbott’s denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for millions of Thais This approval builds on Abbott’s biosimilar portfolio in Asia Pacific, following recent launches in Malaysia and…
